These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8222463)

  • 1. Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.
    Mac-Kay MV; Sanchez Burson J; Martinez-Lanao J; Dominguez-Gil A
    Clin Pharmacokinet; 1993 Sep; 25(3):243-57. PubMed ID: 8222463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an in vitro dialysis system to predict drug removal.
    Hudson JQ; Comstock TJ; Feldman GM
    Nephrol Dial Transplant; 2004 Feb; 19(2):400-5. PubMed ID: 14736965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin dosing in haemodialysis patients and Bayesian estimate of individual pharmacokinetic parameters.
    Keller F; Hörstensmeyer C; Looby M; Borner K; Pommer W; Erdmann K; Giehl M
    Int J Artif Organs; 1994 Jan; 17(1):19-26. PubMed ID: 8188395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidism.
    Tsuruoka S; Yamamoto H; Ioka T; Ando H; Saito T; Fujimura A
    Br J Clin Pharmacol; 2004 Nov; 58(5):488-95. PubMed ID: 15521896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
    Zoer J; Schrander-van der Meer AM; van Dorp WT
    Pharm World Sci; 1997 Aug; 19(4):191-6. PubMed ID: 9297732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decrease in the concentration of tobramycin, vancomycin and phenobarbital in administration with infusion filter].
    Böhrer H; Zhang CH; Krier C
    Infusionstherapie; 1991 Apr; 18(2):96-100. PubMed ID: 1856006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model.
    Schentag JJ; Adelman MH
    Drug Intell Clin Pharm; 1983; 17(7-8):528-31. PubMed ID: 6688217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.
    Zantvoort FA; Wagenvoort JH; Derkx FH; Michel MF
    Br J Clin Pharmacol; 1987 Oct; 24(4):511-8. PubMed ID: 3689631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching individualized antibiotic dosage regimens by means of two computer-assisted learning programs.
    Le Normand Y; Drugeon HB; Potel G; Kergueris MF; Raffi F; Milpied N; Douet MC; Caillon J; Roźe JC
    Int J Biomed Comput; 1994 Jun; 36(1-2):117-9. PubMed ID: 7927849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vancomycin and gentamicin dialysis clearance using in vivo and in vitro systems.
    Pinner NA; Canada RB; Broyles JE; Hudson JQ
    Ren Fail; 2012; 34(6):703-7. PubMed ID: 22463708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
    Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
    Sica DA; Gehr TW; Fernandez A
    Drug Saf; 2000 May; 22(5):350-60. PubMed ID: 10830252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.